1. Home
  2. SNTI vs VBIX Comparison

SNTI vs VBIX Comparison

Compare SNTI & VBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNTI
  • VBIX
  • Stock Information
  • Founded
  • SNTI 2016
  • VBIX N/A
  • Country
  • SNTI United States
  • VBIX Israel
  • Employees
  • SNTI N/A
  • VBIX N/A
  • Industry
  • SNTI Biotechnology: Pharmaceutical Preparations
  • VBIX Computer Software: Prepackaged Software
  • Sector
  • SNTI Health Care
  • VBIX Technology
  • Exchange
  • SNTI Nasdaq
  • VBIX Nasdaq
  • Market Cap
  • SNTI 39.6M
  • VBIX 35.8M
  • IPO Year
  • SNTI N/A
  • VBIX N/A
  • Fundamental
  • Price
  • SNTI $1.78
  • VBIX $3.41
  • Analyst Decision
  • SNTI Strong Buy
  • VBIX
  • Analyst Count
  • SNTI 2
  • VBIX 0
  • Target Price
  • SNTI $8.50
  • VBIX N/A
  • AVG Volume (30 Days)
  • SNTI 139.1K
  • VBIX 21.3K
  • Earning Date
  • SNTI 11-13-2025
  • VBIX 08-14-2025
  • Dividend Yield
  • SNTI N/A
  • VBIX N/A
  • EPS Growth
  • SNTI N/A
  • VBIX N/A
  • EPS
  • SNTI N/A
  • VBIX N/A
  • Revenue
  • SNTI N/A
  • VBIX $14,620,000.00
  • Revenue This Year
  • SNTI N/A
  • VBIX N/A
  • Revenue Next Year
  • SNTI $150.00
  • VBIX N/A
  • P/E Ratio
  • SNTI N/A
  • VBIX N/A
  • Revenue Growth
  • SNTI N/A
  • VBIX N/A
  • 52 Week Low
  • SNTI $1.26
  • VBIX $2.42
  • 52 Week High
  • SNTI $16.94
  • VBIX $12.00
  • Technical
  • Relative Strength Index (RSI)
  • SNTI 73.44
  • VBIX N/A
  • Support Level
  • SNTI $1.36
  • VBIX N/A
  • Resistance Level
  • SNTI $1.75
  • VBIX N/A
  • Average True Range (ATR)
  • SNTI 0.08
  • VBIX 0.00
  • MACD
  • SNTI 0.05
  • VBIX 0.00
  • Stochastic Oscillator
  • SNTI 95.45
  • VBIX 0.00

About SNTI Senti Biosciences Inc.

Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.

About VBIX Viewbix Inc. Common Stock

ViewBix Inc operates in the field of digital advertising. Along with its subsidiaries, the company performs two main activities that are reported as separate operating segments: the search segment and the digital content segment. Maximum revenue is generated from the digital content segment, which is engaged in the creation and editing of content, in different languages, for different target audiences, to generate revenues from advertising platforms, including Google, Facebook, Yahoo, and Apple, by utilizing such content to obtain internet user traffic for its customers. The search segment develops various technological software solutions, which perform automation, optimization, and monetization of internet campaigns, to obtain and route internet user traffic to its customers.

Share on Social Networks: